NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BobcatBio

Private
Hummelstown, PennsylvaniaHealthcare & Life Sciences

Last Round

Series A

Extension

Feb 25, 2025

Est. Valuation

$49.8M

Total Funding Raised

$33.62M

Company Overview

BobcatBio is a biotechnology company that develops cancer-specific immunotherapy for the treatment of solid tumors. The company's adoptive cell therapy approach is designed to elicit a polyclonal immune response against multiple tumor antigens.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

macrophage cell therapyadoptive cell therapyautologous cell therapycell therapyimmuno-oncologysolid tumor treatmentcancer immunotherapynon-genetically modified therapylymphoma treatmentclinical-stage biotechcontract development and manufacturing organizationCDMO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BobcatBio Comparables

Compare BobcatBio with similar companies based on industry and business-model similarity.

BobcatBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

BobcatBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionFeb 25, 2025
SeedSep 29, 2021
Series AJul 23, 2021

BobcatBio Investors

Notable investors and investment history

BobcatBio investors
InvestorRounds
Life Sciences Greenhouse InvestmentsSeries A
Georgia Research AllianceSeries A
SeedFolioSeries A
BioAdvance CapitalSeed, Series A, Series A Extension
Vision Seed CapitalSeed
Bios PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2025

    $7M round led by BioAdvance Capital

  • Sep 29, 2021

    $115K round from BioAdvance Capital and Vision Seed Capital.

BobcatBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BobcatBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BobcatBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersHummelstown, Pennsylvania
Employee Range8
Year Founded2020
Last FundingFeb 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.